• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Healthcare Cold Chain Logistics Market Report & Forecast (2012-2017) Product Image

Global Healthcare Cold Chain Logistics Market Report & Forecast (2012-2017)

  • Published: November 2012
  • Region: Global
  • 91 Pages
  • IMARC Group

FEATURED COMPANIES

  • American Airlines Cargo
  • Cavalier Logistics
  • Continental Air Cargo
  • DB Schenker
  • DHL
  • Fedex
  • MORE

Driven by a strong growth in the sales of temperature sensitive healthcare products, the demand for cold chain logistic services is currently experiencing explosive growth. IMARC Group, one of the world's leading research and advisory firms, finds that the total size of the healthcare cold chain logistic services market is expected to expand from its current figures of US$ 6.7 billion to nearly US$ 10.7 billion by 2017.

This report, an updated and far more extensive and analytical version of our popular 2011 study, provides a comprehensive insight into the logistic opportunities in the global healthcare market. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three aspects of the global healthcare cold chain logistics market.

The first aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes. The second aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive READ MORE >

1 Research Methodology & Market Definitions

2 Executive Summary

3 The Global Healthcare Cold Chain Logistics Market
3.1 Current Trends
3.1.1 Healthcare Cold Chain Products are Exhibiting Exponential Growth
3.1.2 Temperature Sensitive Healthcare Products Have Well Defined Logistic Needs
3.1.3 Outsourcing Trends in Research & Manufacturing Have Increased Logistic Demands
3.1.4 Increasing Regulatory Focus on the Integrity of Transported Healthcare Products
3.1.5 Cost is Not Always the Most Important Driver in Supplier Decisions

4 The Global Healthcare Cold Chain Products Market
4.1 Current Market Trends & Forecast
4.2 Market Segments
4.2.1 Biopharmaceuticals
4.2.1.1 Current Market Trends & Forecast
4.2.1.2 Cold Chain Requirements for Biopharmaceuticals
4.2.1.3 Cold Chain Opportunities for Biopharmaceuticals
4.2.2 Vaccines
4.2.2.1 Current Market Trends & Forecast
4.2.2.2 Cold Chain Requirements for Vaccines
4.2.2.3 Cold Chain Opportunities for Vaccines
4.2.3 Clinical Trial Materials
4.2.3.1 Current Market Trends & Forecast
4.2.3.2 Cold Chain Requirements for Clinical Trial Materials
4.2.3.3 Cold Chain Opportunities for Clinical Trial Materials

5 Healthcare Cold Chain Logistics: How Does It Operate?
5.1 Cold Chain Packaging & Transportation Methods
5.1.1 Dry Ice
5.1.2 Liquid Nitrogen
5.1.3 Gel Packs
5.2 Modeling the Cost of Cold Chain Packaging & Transportation
5.3 Setting Up a Cold Chain
5.3.1 Initial Considerations
5.3.2 Choosing the Correct Model
5.3.3 Regulatory/Custom Clearance
5.3.4 Final Stages
5.3.5 Quality Assurance

6 The Healthcare Cold Chain Logistic Services Market
6.1 Current Market Trends
6.2 Market Forecast
6.3 Market Segmentation
6.3.1 Market by Product
6.3.1.1 Biopharmaceuticals & Vaccines
6.3.1.2 Clinical Trial Materials
6.3.2 Market by Segment
6.3.2.1 Packaging & Instrumentation
6.3.2.2 Transportation
6.3.3 Market by Region
6.3.3.1 North America
6.3.3.2 Europe
6.3.3.3 Asia Pacific
6.3.3.4 Rest of the World

7 Challenges in the Healthcare Cold Chain Logistics Market
7.1 Cold Chain Infrastructure Remains Underdeveloped in Many Regions
7.2 Lack of Funding to Implement an Efficient Cold Chain Infrastructure
7.3 New Technologies Nullifying the Need of Cold Chains

8 Key Company Profiles
8.1 World Courier
8.2 DHL
8.3 Fedex
8.4 United Parcel Service
8.5 Kuehne and Nagel
8.6 Cavalier Logistics
8.7 DB Schenker
8.8 Life ConEx
8.9 American Airlines Cargo
8.10 Continental Air Cargo
8.11 Marken

List of Figures

Figure 3 1: Global – Healthcare Cold & Non Cold Chain Products Market (in Billion US$), 2005-2011
Figure 3 2: Global – Healthcare Cold & Non Cold Chain Products Market Forecast (in Billion US$), 2012-2017
Figure 3 3: Global – Potency of the Tetanus Component of a DTP Vaccine Stored for 45 Days at Various Temperatures
Figure 3 4: Global – Contract Research & Manufacturing Market (in Billion US$), 2007-2011
Figure 3 5: Global – Contract Research & Manufacturing Market Forecast (in Billion US$), 2012-2017
Figure 3 6: Estimated Costs incurred in Various Pharmaceutical Operations
Figure 4 1: Global – Healthcare Cold Chain Products Market – Break up by Product (in %), 2005-2011
Figure 4 2: Global – Healthcare Cold Chain Products Market Forecast – Break up by Product (in %), 2012-2017
Figure 4 3: Global – Biopharmaceutical Market (in Billion US$), 2005-2011
Figure 4 4: Global – Biopharmaceutical Market Forecast (in Billion US$), 2012-2017
Figure 4 5: US & Europe – Biosimilar Sales & Forecast (in Million US$), 2008-2017
Figure 4 6: Global – Share of Biopharmaceutical Manufacturers Planning to Outsource Some Production to Contract Manufacturers (in %), 2006 & 2011
Figure 4 7: Global – Biopharmaceutical Contract Manufacturing Market (in Billion US$), 2010 & 2011
Figure 4 8: Global – Biopharmaceutical Contract Manufacturing Market Forecast (in Billion US$), 2012 – 2017
Figure 4 9: Global – Vaccine Market (in Billion US$), 2005-2011
Figure 4 10: Global – Vaccine Market Forecast (in Billion US$), 2012-2017
Figure 4 11: Global – Vaccine Production Volume by Region (in %), 2008
Figure 4 12: Europe – Vaccine Export Volume by Region (in %), 2008
Figure 4 13: Global – Clinical Trials Market (in Billion US$), 2005-2011
Figure 4 14: Global – Clinical Trials Market – Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2009 – 2011
Figure 4 15: Time Taken for Biopharmaceuticals to Get Approved (in Months), 1982-2009
Figure 4 16: Global – Clinical Trials Market Forecast (in Billion US$), 2012-2017
Figure 4 17: Global – Clinical Trials Market Forecast – Spending on Biopharmaceuticals & Small Molecule Drugs (in Billion US$), 2012-2017
Figure 4 18: Number of Multinational Clinical Trials (Phase II and III) in Asian Countries by the Top Twenty Global Pharmaceutical Companies*
Figure 4 19: Global – Break up of Biopharmaceuticals & Small Molecule Drugs in Preclinical & Clinical trials, (in %), 2009
Figure 4 20: Top Reasons for Conducting Clinical Trials in Each Country (in %), 2009
Figure 5 1: A Typical Drug Supply Chain from the Manufacturer to the End User
Figure 6 1: Global – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2002-2011
Figure 6 2: Global – Healthcare Cold Chain Packaging & Instrumentation Services Market (in Billion US$), 2002-2011
Figure 6 3: Global – Healthcare Cold Chain Logistic Services Market by Region (in %), 2008, 2011, 2014 & 2017
Figure 6 4: North America – Healthcare Cold Chain Logistic Services Market – (in Billion US$), 2008-2011
Figure 6 5: North America – Healthcare Cold Chain Logistic Services Market Forecast – (in Billion US$), 2012-2017
Figure 6 6: Europe – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2011
Figure 6 7: Europe – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2012-2017
Figure 6 8: Asia Pacific – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008-2011
Figure 6 9: Asia Pacific – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2012-2017
Figure 6 10: Rest of the World – Healthcare Cold Chain Logistic Services Market (in Billion US$), 2008 – 2011
Figure 6 11: Rest of the World – Healthcare Cold Chain Logistic Services Market Forecast (in Billion US$), 2012-2017
Figure 7 1: Financing Sources and Gaps (in %), 2008-2010

List of Tables

Table 3 1: Various Regulations on Healthcare Cold Chain Logistic Requirements
Table 4 1: Global – Healthcare Cold Chain Products Market – Break up by Product (in Billion US$), 2005-2011
Table 4 2: Global – Healthcare Cold Chain Products Market Forecast – Break up by Product (in Billion US$), 2012-2017
Table 4 3: Global – Biopharmaceutical Market – Sales by Class (in Billion US$), 2005-2011
Table 4 4: Global – Biopharmaceutical Market Forecast – Sales by Class (in Billion US$), 2012-2017
Table 4 5: Stability of Various Biopharmaceuticals at Room Temperature
Table 4 6: US & Europe – Launch Dates of Various Biosimilars
Table 4 7: US & Europe – Biosimilar Market Sales & Forecast (in Million US$), 2008-2017
Table 4 8: Complexity of the Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
Table 4 9: Temperature Stability of Commonly Used Vaccines
Table 4 10: The Effect of Temperature Excursions on the Usability of Vaccines
Table 4 11: Global – Major Vaccine Production Sites (in Numbers), 2008
Table 4 12: Global – Patent Expiry Risks of Big Pharmaceutical Companies, 2011-2013
Table 4 13: Ideal Storage Temperatures for Clinical Trial Materials
Table 5 1: Average Amount of Dry Ice for Packaging Frozen Goods in a Single Well Insulated Container
Table 5 2: Dry Ice Containers
Table 5 3: Refrigerated Shipping Containers with Gel Packs
Table 5 4 : Costs Associated With the Cold Chain Shipment of Healthcare Products, 2011*
Table 5 5 : Costs Associated With the Non-Cold Chain Shipment of Healthcare Products, 2011*
Table 7 1: Cold Chain & Logistic Funding Gaps Per Infant (in US$), 2008-2010

- World Courier
- DHL
- Fedex
- United Parcel Service
- Kuehne and Nagel
- Cavalier Logistics
- DB Schenker
- Life ConEx
- American Airlines Cargo
- Continental Air Cargo
- Marken

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos